Joseph J. Taylor's research while affiliated with Brigham and Women's Hospital and other places

Publications (15)

Article
Full-text available
Psychiatric disorders share neurobiology and frequently co-occur. This neurobiological and clinical overlap highlights opportunities for transdiagnostic treatments. In this study, we used coordinate and lesion network mapping to test for a shared brain network across psychiatric disorders. In our meta-analysis of 193 studies, atrophy coordinates ac...
Article
Objective: This study was undertaken to test whether lesions causing central poststroke pain (CPSP) are associated with a specific connectivity profile, whether these connections are associated with metabolic changes, and whether this network aligns with neuromodulation targets for pain. Methods: Two independent lesion datasets were utilized: (1...
Article
Interventional Psychiatry is an emerging subspecialty that treats patients with disorders resistant to routine measures by employing advanced treatment modalities and procedures that require expertise beyond the training provided in a general psychiatric residency. Interventional psychiatrists thus require advanced technical, psychiatric, and gener...
Article
Full-text available
Background Seizures are rare during repetitive transcranial magnetic stimulation (rTMS) treatment, but estimating risk is difficult because of study heterogeneity and sampling limitations. Moreover, there are few studies comparing rates between device manufacturers. Objective The objective of this study was to calculate rTMS seizure rates across v...
Article
Full-text available
There are currently no validated treatment biomarkers in psychiatry. Resting State Functional Connectivity (RSFC) is a popular method for investigating the neural correlates of mood disorders, but the breadth of the field makes it difficult to assess progress toward treatment response biomarkers. In this review, we followed general PRISMA guideline...

Citations

... Although there is increasing interest in using functional connectivity to inform target site selection in basic research settings (Eldaief et al., 2011;Halko et al., 2014;Lynch et al., 2019; and for TMS interventions (Cash et al., 2019;Cole et al., 2022;Fox et al., 2012;Klooster et al., 2022;Siddiqi et al., 2022), most conventional TMS protocols are not guided by the individual patient's functional brain organization. Instead, generic coil placements based on scalp heuristics (Beam et al., 2009;Mir-Moghtadaei et al., 2022) or stereotaxic coordinates derived from group-average functional maps (Blumberger et al., 2018;Weigand et al., 2018) have been used. ...
... Neuroimaging has revealed important insights into the neurobiological basis of psychiatric illness [48][49][50][51][52][53][54][55][56][57] . However, prior work has critical limitations that we seek to address. ...
... TMS has few side effects, including local pain, discomfort, and headache [37]. While a seizure remains a significant potential side effect, current rates of TMS-induced seizures are low (0.31 per 10000 sessions [3,38]). ...
... Particularly, the task-free version-known as resting state fMRI-is better tolerated by clinical populations, and circumvents the need for stringent subject compliance. Today, resting state fMRI features are being rigorously examined to identify potential biomarkers for diagnosis and prognosis of different brain disorders (Abraham et al., 2017;Chen et al., 2022;Damoiseaux, 2012;Drysdale et al., 2017;Franzmeier et al., 2017;Hohenfeld et al., 2018;Khalili-Mahani et al., 2017;Pfannmöller & Lotze, 2019;Rashid & Calhoun, 2020;Taylor et al., 2021;Viviano et al., 2018;Wang et al., 2018). ...